Eversept Partners’s Intuitive Surgical ISRG Stock Holding History

Eversept Partners’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.13M	Sell	11,119 -6,943	-38%	-$3.51M	0.27%	59
2025 Q4	$10.2M	Buy	18,062 +3,636	+25%	+$1.94M	0.52%	52
2025 Q3	$6.45M	Buy	+14,426	New	+$6.92M	0.44%	47
2022 Q4	–	Sell	-9,125	Closed	-$1.71M	–	72
2022 Q3	$1.71M	Buy	9,125 +534	+6%	+$115K	0.15%	51
2022 Q2	$1.72M	Buy	8,591 +428	+5%	+$100K	0.12%	57
2022 Q1	$2.46M	Sell	8,163 -1,662	-17%	-$486K	0.19%	60
2021 Q4	$3.53M	Buy	9,825 +390	+4%	+$134K	0.23%	69
2021 Q3	$3.13M	Buy	9,435 +1,686	+22%	+$566K	0.22%	62
2021 Q2	$2.38M	Hold	7,749	–	–	0.16%	63
2021 Q1	$1.91M	Buy	+7,749	New	+$1.95M	0.14%	61

Other funds holding ISRG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eversept Partners's ISRG Position: Q1 2026 in Review

Eversept Partners reduced its Intuitive Surgical (ISRG) stake by 38% in Q1 2026, selling an estimated $3.51M and leaving 11,119 shares worth $5.13M. The position accounts for 0.27% of the portfolio, ranked #59.

Eversept Partners first reported a position in ISRG in Q1 2021 and has held it in 10 quarters since. The position peaked at $10.2M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

Eversept Partners held 11,119 shares of Intuitive Surgical worth $5.13M as of Q1 2026.
Eversept Partners sold 6,943 Intuitive Surgical shares in Q1 2026, an estimated $3.51M.
Intuitive Surgical made up 0.27% of Eversept Partners's portfolio in Q1 2026, its #59 holding.
Eversept Partners first reported a position in Intuitive Surgical in Q1 2021 and has held it in 10 quarters since.
Eversept Partners's Intuitive Surgical position peaked at $10.2M in Q4 2025.
2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.